Meridian Bioscience (VIVO)

[stockvaper]

Meridian Bioscience to Provide Reagents for Production of Tens of Millions of COVID-19 Antibody Tests
BY MT Newswires
05/26/2020
(MT Newswires) -- Meridian Bioscience ( VIVO ) said that it will provide its SARS-CoV-2 antigens and related reagents for the production of tens of millions of COVID-19 antibody tests per month.

Those antigens and related reagents are part of assays granted Emergency Use Authorization by the US Food and Drug Administration, the company said.

Price: 16.10, Change: +1.27, Percent Change: +8.56

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.